[{"Assets_0_FY_USD":60683000000.0,"EarningsPerShareDiluted_4_FY_USD":-2.35,"EarningsPerShareDiluted_1_FY_USD":-2.85,"EarningsPerShareBasic_1_FY_USD":-2.85,"EarningsPerShareBasic_4_FY_USD":-2.35,"StockholdersEquityConverted_0_FY_USD":15794000000.0,"StockholdersEquity_0_FY_USD":14707000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":1021.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":1021.0,"NetIncomeLossConverted_1_FY_USD":-2886000000.0,"NetIncomeLossConverted_4_FY_USD":-2150000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":2446000000.0,"CommonStockSharesConverted_0_FY_shares":1196000000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":0.0,"RevenuesConverted_4_FY_USD":18854000000.0,"RevenuesConverted_1_FY_USD":4559000000.0,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20190219"}]